Senna and Perforomist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna (senna) and Perforomist (formoterol fumarate). Common drug interactions include sinusitis among females and bacterial infection among males.

The phase IV clinical study analyzes what interactions people have when they take Senna and Perforomist. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Perforomist?

Perforomist has active ingredients of formoterol fumarate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 1,431 Perforomist users. Check the latest studies of Perforomist.



On Jul, 24, 2026

16 people who take Senna and Perforomist together, and have interactions are studied.

Senna and Perforomist drug interactions.

What are the common drug interactions of Senna and Perforomist, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Vomiting
  3. Bacterial infection
  4. Kidney infection
  5. Multiple allergies (allergy to multiple agents)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Ankle fracture
  8. Arthralgia (joint pain)
  9. Headache (pain in head)
  10. Oxygen saturation decreased

male:

  1. Bacterial infection
  2. White blood cell count decreased

What are the common drug interactions of Senna and Perforomist, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiac disorder
  2. Chest pain

60+:

  1. Ankle fracture
  2. Emotional disorder

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 56.25%
  2. Depression: 3 people, 18.75%
  3. Itching: 2 people, 12.50%
  4. Acute Pulmonary Oedema (sudden deposit of fluid in the lung)): 2 people, 12.50%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 12.50%
  6. Flatulence (flatus expelled through the anus): 2 people, 12.50%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  8. Hypersensitivity: 2 people, 12.50%
  9. Skin Bacterial Infection: 2 people, 12.50%
  10. Indigestion: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Perforomist?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Senna and Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Senna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perforomist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on senna and formoterol fumarate (the active ingredients of Senna and Perforomist, respectively), and Senna and Perforomist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: